Trump ends U.S. nuclear-testing moratorium, raising concerns about an arms race and global nonproliferation efforts.
Trump seizes on Gates' memo downplaying climate change apocalypse, sparking debate over priorities ahead of COP30.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Trump ends U.S. nuclear-testing moratorium, raising concerns about an arms race and global nonproliferation efforts.
Trump seizes on Gates' memo downplaying climate change apocalypse, sparking debate over priorities ahead of COP30.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.